A Study of Once-Daily Oral Orforglipron (LY3502970) in Japanese Adult Participants With Obesity Disease
Clinical trial NCT05931380 · COMPLETED
Trial details
- NCT number
- NCT05931380
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-31
- Primary completion
- 2025-06-19
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.